Fludarabine-treosulfan compared to thiotepa-busulfan-fludarabine or FLAMSA as conditioning regimen for patients with primary refractory or relapsed acute myeloid leukemia: a study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT)

Saraceni, Francesco ; Labopin, Myriam ; Brecht, Arne ; Kröger, Nicolaus ; Eder, Matthias ; Tischer, Johanna ; Labussière-Wallet, Hélène ; Einsele, Hermann ; Beelen, Dietrich ; Bunjes, Donald ; Niederwieser, Dietger ; Bochtler, Tilmann ; Savani, Bipin N ; Mohty, Mohamad ; Nagler, Arnon

Journal of hematology and oncology, 2019-04, Vol.12 (1), p.44-44, Article 44 [Periódico revisado por pares]

England: BioMed Central Ltd

Texto completo disponível